Systemic anti-inflammatory fibrosis suppression in threatened trabeculectomy failure

Clinical and Experimental Ophthalmology

Volumn 32, Issue 1, 2004, Pages 81-86

  Vote, Brendan ^a,b   Fuller, J Robert ^a   Bevin, Tui H ^a   Molteno, Anthony C B ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE   (United Kingdom)

Author keywords

Anti inflammatory fibrosis suppression; Aqueous; Fibrosis; Trabeculectomy

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; ATROPINE; CATECHOL METHYLTRANSFERASE; CODEINE PHOSPHATE; COLCHICINE; DICLOFENAC; FLUOROURACIL; GLUCOCORTICOID; KININ; MITOMYCIN C; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROSTAGLANDIN;

ANTIINFLAMMATORY ACTIVITY; CLINICAL FEATURE; CUSHINGOID SYNDROME; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; EYE INFLAMMATION; FIBROSIS; GASTROINTESTINAL SYMPTOM; GLAUCOMA; GLAUCOMA DRAINAGE IMPLANT; HUMAN; INFECTION COMPLICATION; INFECTION RISK; INTRAOCULAR PRESSURE ABNORMALITY; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; REVIEW; SURGICAL INFECTION; SURGICAL TECHNIQUE; TRABECULECTOMY; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS; ATROPINE; BLISTER; COLCHICINE; CONJUNCTIVA; DICLOFENAC; DRUG THERAPY, COMBINATION; EPINEPHRINE; FIBROSIS; GLAUCOMA; HUMANS; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; PREDNISONE; TRABECULECTOMY; TREATMENT FAILURE;

EID: 1542610145     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-9071.2004.00765.x     Document Type: Review

References (50)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93.
2. Sommer A. Doyne Lecture. Glaucoma facts and fancies. Eye 1996; 10: 295-301.
3. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994; 101: 1651-7.
4. Galin MA. External fistulizing surgery. In: New Orleans Academy of Ophthalmology, ed. Symposium on Glaucoma. St Louis: Mosby, 1976; 266-74.
5. Hu C, Matsuo H, Tomita G et al. Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients. Ophthalmology 2003; 110: 345-52.
6. Skuta GL, Parrish RKII. Wound healing in glaucoma filtering surgery. Surv Ophthalmol 1987; 32: 149-70.
7. Traverso CE, Tomey KF, Gandolfo E. The glaucomas in pseudophakia. Curr Opin Ophthalmol 1996; 7: 65-71.
8. Joseph JP, Miller MH, Hitchings PA. Wound healing as a barrier to successful filtration surgery. Eye 1988; 2 (Suppl.): S113-23.
9. Addicks EM, Quigley HA, Green WR et al. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983; 101: 795-8.
10. Hitchings RA, Grierson I. Clinicopathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983; 103: 84-8.
11. Grierson I, Joseph J, Miller M et al. Wound repair: The fibroblast and the inhibition of scar formation. Eye 1988; 2: 135-48.
12. Spencer WH. Symposium: Microsurgery of the outflow channels. Histologic evaluation of microsurgical glaucoma techniques. Trans Am Acad Ophthalmol Otolaryngol 1972; 76: 389-97.
13. Miller MH, Grierson I, Unger WI et al. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg 1989; 20: 350-7.
14. Chang L, Crowston JG, Cordiero MF, Akbar AN, Khaw PT. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol 2000; 45: 49-68.
15. Parrish RK, Folberg R. Wound healing in glaucoma surgery. In: Ritch R, Shields MB, Krupin T, eds. The Glaucomas, 2nd edn. Sydney: Mosby, 1996; 1633-51.
16. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-β2 antibody: A new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 1999; 40: 2225-34.
17. Starita RJ, Fellman RL, Spaeth GL et al. Short- and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmology 1985; 92: 939-46.
18. Araujo SV, Spaeth GL, Roth SM et al. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteriods after trabeculectomy. Ophthalmology 1995; 102: 1753-9.
19. Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 1984; 102: 598-604.
20. Miller MH, Joseph NH, Wishart PK et al. Lack of beneficial effect of intensive topical steroids and beta irradiation of eyes undergoing repeat trabeculectomy. Ophthalmic Surg 1987; 18: 508-12.
21. Dueker DK. Discussion on Starita et al. Short and long-term effects of postoperative corticosteroids on trabeculectomy. Ophthalmology 1985; 92: 945-6.
22. Barnes RM, Mora JS, Best SJ. Beta radiation as an adjunct to low-risk trabeculectomy. Clin Experiment Ophthalmol 2000; 28: 259-62.
23. Miller MH, Rice NS. Trabeculectomy combined with beta irradiation for congenital glaucoma. Br J Ophthamol 1991; 75: 584-90.
24. Khaw PT, Ward S, Grierson I, Rice NS. Effect of beta irradiation on proliferating human Tenon's capsule fibroblasts. Br J Ophthalmol 1991; 75: 580-3.
25. Migdal C, Hitchings R. Effect of antiprostaglandins on glaucoma filtration surgery. Trans Ophthalmol Soc UK 1982; 102: 129-32.
26. Migdal C, Hitchings R. The developing bleb: Effect of topical antiprostaglandins on the outcome of glaucoma fistulising surgery. Br J Ophthalmol 1983; 67: 655-60.
27. Nguyen KD, Lee DA. Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2693-701.
28. Molteno ACB, Dempster AG. Methods of controlling bleb fibrosis around draining implants. In: Mills KB, ed. Glaucoma: Proceedings of the Fourth International Symposium of the Northern Eye Institute, Manchester, UK. Oxford: Pergamon Press, 1988; 192-211.
29. Molteno ACB, Straughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S Afr Med J 1976; 50: 881-5.
30. Pablo LE, Ramirez T, Alvarez R et al. Morphometric study of wound healing in a model of filtering surgery with mitomycin-C. Eur J Ophthalmol 1995; 5: 168-71.
31. The Fluorouracil Filtering Surgery Study Group. Fluorouracil Filtering Surgery Study one-year follow-up. Am J Ophthalmol 1989; 108: 625-35.
32. Smith S, D'Amore PA, Dreyer EB. Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. Am J Ophthalmol 1994; 118: 332-7.
33. Khaw PT, Sherwood MB, MacKay SL, Rossi MJ, Schultz G. Five minute treatments with fluorouracil, floxuridine and mitomycin have long term effects on human Tenon's capsule fibroblasts. Arch Ophthalmol 1992; 110: 1150-54.
34. Khaw PT, Ward S, Porter A, Grierson I, Hitchings RA, Rice NS. The long term effects of 5-flourouracil and sodium butyrate on human Tenon's fibroblasts. Invest Ophthalmol Vis Sci 1992; 33: 2043-52.
35. Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT. Antimetabolite-induced apoptosis in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci 1998; 39: 449-54.
36. Occleston NL, Daniels JT, Tarnuzzer RW et al. Single exposures to antiproliferatives. Long-term effects on ocular fibroblast wound-healing behaviour. Invest Ophthalmol Vis Sci 1997; 38: 1998-2007.
37. Schwartz AL, Weiss HS. Bleb leak with hypotony after laser suture lysis and trabeculectomy with mitomycin-C. Arch Ophthalmol 1992; 110: 1049.
38. Jampel HD, Pasquale LR, Dibernardo C. Hypotony maculopathy following trabeculectomy with mitomycin C. Arch Ophthalmol 1992; 110: 1049-50.
39. Wolner B, Liebmann JM, Sassani JW et al. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology 1991; 98: 1053-60.
40. Higginbotham EJ, Stevens RK, Musch DC et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996; 103: 650-56.
41. Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 1968; 66: 673-9.
42. La Place PS Marquis de. Traite de Mécanique Céleste (Supplément à la Théeorie de l'Action Capillaire). Paris: Courcier, 1807.
43. Young T. An essay on the cohesion of fluids. Phil Trans Roy Soc Lond 1805; 95: 65-87.
44. Molteno ACB. Mechanisms of intraocular inflammation. Trans Ophthalmol Soc NZ 1980; 32: 69-72.
45. Molteno ACB. New implant for glaucoma - clinical trial. Br J Ophthalmol 1969; 53: 606-15.
46. Rocha e Silva M, Garcia Leme J. Anti-inflammatory action of drugs. In: Rocha e Silva M, Garcia Leme J, eds. Chemical Mediators of the Acute Inflammatory Reaction. New York: Pergamon Press, 1972; 199-238.
47. Stanbury RM, Graham EM. Systemic corticosteroid therapy - side effects and their management. Br J Ophthalmol 1998; 82: 704-8.
48. Lemor M, Yeo JH, Glaser BM. Oral colchicine for the treatment of experimental traction retinal detachment. Arch Ophthalmol 1986; 104: 1226-9.
49. Fuller JR, Bevin TH, Molteno ACB, Vote BJT, Herbison P. Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications. Br J Ophthalmol 2002; 86: 1352-5.
50. Molteno ACB, Sayawat N, Herbison P. Otago Glaucoma Surgery Outcome Study. Long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 2001; 108: 605-13.